Joseph Sci Borg/LinkedIn
Oct 11, 2026, 14:09
Joseph Sci Borg: The Haemoglobin Switch as a Programmable Biological Transition
Joseph Sci Borg, Scientist at BioAstra, shared a post on LinkedIn:
“The haemoglobin switch may not be a gene switch at all, it may be a programmable transition between two biological states.
And that’s why we are approaching it from different directions.
Earth based research (that has already been going on for high 40 years) , high altitude travel and space flight research (which our groups bring to the table) and a host of other things in between.
Let’s see what we learn next ! But so far it’s incredible what very rare clinical phenotypes in Malta families can reveal.”
Stay updated with Hemostasis Today.
-
Oct 11, 2026, 15:31Muhammad Alvi: CASPR Study Explores Treatment Response Across ESUS Phenotypes
-
Oct 11, 2026, 15:15Thalassaemia International Federation Joins ASCAT 2026 to Advance Sickle Cell and Thalassaemia Care
-
Oct 11, 2026, 15:14Challenges and Perspectives on Gene Therapy in Hemophilia A – Seminars in Thrombosis and Hemostasis
-
Oct 11, 2026, 15:07Neysa Rahardjo: Platelet Estimation Pitfalls and Discrepancy Resolution
-
Oct 11, 2026, 15:05Lance Trewhella: Reflections from the ASCLS Region V Fall Symposium
-
Oct 11, 2026, 15:04The Anti-Inflammatory Rationale for GLP-1 Agonists in Hemophilia – CRH French Reference Center for Hemophilia Lyon
-
Oct 11, 2026, 15:00Donja W.: Blood Shortages Aren’t Just Statistics
-
Oct 11, 2026, 14:54Archil Jaliashvili: NHSBT Highlights Persistent Gaps in Matched Blood for Sickle Cell Patients
-
Oct 11, 2026, 14:46Sebastien Lobet: Physiotherapy and Joint Health Across the Spectrum of Bleeding Disorders